A decision from a federal court judge in Texas to strip long-standing government approval for a commonly used abortion drug has alarmed abortion rights groups and providers, who are bracing and preparing for whatever could come next.
On 7 April, US District Judge Matthew Kacsmaryk, who has a history of right-wing activism, sided with anti-abortion activists in a legal challenge against the US Food and Drug Administration’s approval of mifepristone, which the agency first approved for use in 2000.
